Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685
-
Narrated by:
-
By:
Summary
Yet more GLP1 news this week.
People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle.
So are a tool that biohackers have known about for years - CGMs - the answer?
Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management.
Follow Sharam Fouladgar-Mercer on LinkedIn.
adbl_web_anon_alc_button_suppression_c
No reviews yet